- Reaction score
- 122
i feel so bad for cassiopea. seriously. they were so excited and so was everyone waiting for it for literal decades. now they have an ineffective expensive drug that you have to apply twice a day worse in every aspect than anything on the market. praised as the anti androgen that would reshape the landscape, even respected dermatologists szggesting this is a break through. i find it honestly depressing not just for me but everyone involved with the company as wellOnly person I recall having results from CB is El Duterino and his hair loss is not aggressive.
CB was so good on paper. it was so good in the first trial at 6 months. i dont understand what was happening after that, clearly it is a potent AA, it got to the follicles. im afraid this can be bad news for other topical agents going the androgen route
Last edited: